CPG
TEVA icon

Cornerstone Planning Group’s Teva Pharmaceuticals TEVA Stock Holding History

Cornerstone Planning Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32K Buy
893
+755
+547% +$24.3K ﹤0.01% 526
2025
Q4 		$4.58K Sell
138
-83
-38% -$2.04K ﹤0.01% 1011
2025
Q3 		$17.6K Buy
221
+165
+295% +$2.9K ﹤0.01% 624
2025
Q2 		$880 Buy
56
+38
+211% +$613 ﹤0.01% 1141
2025
Q1 		$257 Sell
18
-87
-83% -$1.55K ﹤0.01% 1439
2024
Q4 		$2.29K Buy
105
+86
+453% +$1.56K ﹤0.01% 762
2024
Q3 		$350 Buy
19
+18
+1,800% +$315 ﹤0.01% 1161
2024
Q2 		$17 Hold
1
– – ﹤0.01% 1235
2024
Q1 		$14 Hold
1
– – ﹤0.01% 1082
2023
Q4 		$10 Hold
1
– – ﹤0.01% 949
2023
Q3 		$10 Buy
+1
New +$9 ﹤0.01% 1192

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Planning Group's TEVA Position: Q1 2026 in Review

Cornerstone Planning Group increased its Teva Pharmaceuticals (TEVA) stake by 547% in Q1 2026, buying an estimated $24.3K and bringing the position to 893 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Cornerstone Planning Group first reported a position in TEVA in Q3 2023 and has held it in 11 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Cornerstone Planning Group held 893 shares of Teva Pharmaceuticals worth $32K as of Q1 2026.
  • Cornerstone Planning Group bought 755 Teva Pharmaceuticals shares in Q1 2026, an estimated $24.3K.
  • Teva Pharmaceuticals made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #526 holding.
  • Cornerstone Planning Group first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.